Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Weidong Han|Journal of Hematology & Oncology|2020Cited by 320
Chimeric Antigen Receptors Modified T-Cells for Cancer TherapyHanren Dai, Weidong Han|JNCI Journal of the National Cancer Institute|2016Cited by 300